サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ブランドジェネリック市場- 薬剤クラス別、用途別、投与経路別、流通チャネル別、世界予測、2023年～2032年
市場調査レポート
商品コード
1368713

ブランドジェネリック市場- 薬剤クラス別、用途別、投与経路別、流通チャネル別、世界予測、2023年～2032年

Branded Generics Market - By Drug Class (Anti-hypertensive, Hormones, Antimetabolites), Application (Oncology, Cardiovascular Diseases), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy), Global Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 180 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ブランドジェネリック市場- 薬剤クラス別、用途別、投与経路別、流通チャネル別、世界予測、2023年～2032年
出版日: 2023年08月28日
発行: Global Market Insights Inc.
ページ情報: 英文 180 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ブランドジェネリックの世界市場規模は、2023年から2032年にかけて顕著な成長率を示します。

ジェネリック医薬品の普及を目指す政府の取り組みは、市場に刺激的な効果をもたらす可能性があります。スイス政府は2023年9月、健康保険条例、医療サービス条例、医薬品条例の改正を承認し、2024年1月1日に施行する予定です。これらの改正は、ジェネリック医薬品の費用対効果を先発医薬品よりも高めると同時に、より高価な選択肢を選択した場合の患者の自己負担額を引き上げることを目的としています。この戦略的な動きは、年間2億5,000万スイスフラン（2億7,500万米ドル相当）の節約を達成するように設計されています。

より安価なジェネリック医薬品の使用を奨励することで、政府の政策が競合環境を作り出し、製薬会社はブランドジェネリック医薬品の製造において技術革新を促します。このような競争により、高品質で費用対効果の高いブランドジェネリック医薬品の種類が増え、医薬品市場の選択肢が増え、価格が下がる可能性があるため、消費者に利益をもたらすことができます。

2032年までには、ブランドジェネリック業界の用途別情勢は、循環器疾患分野が支配的となる可能性があります。患者やヘルスケア専門家は、重要な医薬品について信頼できるブランド名を好むことが多く、信頼性と品質が保証されます。さらに、ブランドジェネリック医薬品は、患者の嗜好やニーズに応える特定の製剤や投与方法を提供することもあります。このような需要は、心血管の健康に対する意識の高まりと、効果的で確立された治療法への注目によってさらに促進されています。

外用ブランドジェネリック市場は2032年まで健全な成長率を示します。外用ブランドジェネリック医薬品の売上は、その有効性、手頃な価格、親しみやすさから増加傾向にあります。消費者は、皮膚やヘルスケア製品についてよく知られたブランド名を信頼し、好んで選択します。外用ブランドジェネリックは多くの場合、ブランド品と同等の品質と性能を低価格で提供し、コスト意識の高い消費者にアピールしています。皮膚の健康に対する意識の高まりと、こうした信頼できる代替品の入手可能性が、市場におけるジェネリック医薬品の人気の高まりに寄与しています。

欧州のブランドジェネリック医薬品業界は、いくつかの重要な要因により力強い成長を遂げています。欧州の消費者は品質を優先し、ジェネリック医薬品であっても定評のあるブランド名を信頼しています。また、同地域のヘルスケア制度は費用対効果の高いジェネリック医薬品の使用を奨励しており、患者と政府予算の双方に利益をもたらしています。規制の枠組みもブランドジェネリックの成長をサポートし、製薬会社が信頼できる代替品を提供するのに有利な環境を作り出しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ブランドジェネリック業界考察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 慢性疾患の有病率の増加
      • 期限切れ特許の増加
      • ジェネリック医薬品を促進する政府の取り組みの増加
    • 業界の潜在的リスク＆課題
      • 標準的なジェネリック医薬品や先発医薬品との競合
      • 規制上の障壁
  • 成長の可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 ブランドジェネリック市場：薬剤クラス別、2018年～2032年

  • 主要動向：薬剤クラス別
  • 降圧剤
  • ホルモン剤
  • 代謝拮抗薬
  • 抗うつ薬
  • アルキル化剤
  • 脂質低下薬
  • 抗てんかん薬
  • 抗精神病薬
  • その他薬剤クラス別

第6章 ブランドジェネリック市場：用途別、2018年～2032年

  • 主要動向：用途別
  • がん領域
  • 心血管疾患
  • 神経疾患
  • 消化器疾患
  • 皮膚科疾患
  • 急性・慢性疼痛
  • その他の用途

第7章 ブランドジェネリック市場：投与経路別、2018年～2032年

  • 主要動向：投与経路別
  • 経口
  • 局所
  • 非経口
  • その他の投与経路

第8章 ブランドジェネリック市場：流通チャネル別、2018年～2032年

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 ブランドジェネリック市場：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第10章 企業プロファイル

  • Teva Pharmaceutical Industries Ltd.
  • Lupin
  • Sanofi
  • Sun Pharmaceutical Industries, Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Endo International plc
  • Pfizer, Inc.
  • Viatris, Inc.
  • Abbott Laboratories
  • Sandoz
図表

Data Tables

  • TABLE 1 Market revenue, by drug class (2022)
  • TABLE 2 Market revenue, by route of administration (2022)
  • TABLE 3 Market share, by application (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global branded generics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global branded generics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 9 Global branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 10 Global branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 11 Global branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 12 Global branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 13 Global branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 14 Global branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 15 Global branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Anti-hypertensive market size, 2018 - 2022 (USD Million)
  • TABLE 18 Anti-hypertensive market size, 2023 - 2032 (USD Million)
  • TABLE 19 Hormones market size, 2018 - 2022 (USD Million)
  • TABLE 20 Hormones market size, 2023 - 2032 (USD Million)
  • TABLE 21 Antimetabolites market size, 2018 - 2022 (USD Million)
  • TABLE 22 Antimetabolites market size, 2023 - 2032 (USD Million)
  • TABLE 23 Anti-depressants market size, 2018 - 2022 (USD Million)
  • TABLE 24 Anti-depressants market size, 2023 - 2032 (USD Million)
  • TABLE 25 Alkylating agents market size, 2018 - 2022 (USD Million)
  • TABLE 26 Alkylating agents market size, 2023 - 2032 (USD Million)
  • TABLE 27 Lipid lowering drugs market size, 2018 - 2022 (USD Million)
  • TABLE 28 Lipid lowering drugs market size, 2023 - 2032 (USD Million)
  • TABLE 29 Anti-epileptics market size, 2018 - 2022 (USD Million)
  • TABLE 30 Anti-epileptics market size, 2023 - 2032 (USD Million)
  • TABLE 31 Anti-psychotics market size, 2018 - 2022 (USD Million)
  • TABLE 32 Anti-psychotics market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other drug classes market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other drug classes market size, 2023 - 2032 (USD Million)
  • TABLE 35 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 36 Oncology market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cardiovascular diseases market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cardiovascular diseases market size, 2023 - 2032 (USD Million)
  • TABLE 39 Neurological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 40 Neurological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 41 Gastrointestinal diseases market size, 2018 - 2022 (USD Million)
  • TABLE 42 Gastrointestinal diseases market size, 2023 - 2032 (USD Million)
  • TABLE 43 Dermatological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 44 Dermatological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 45 Acute & chronic pain market size, 2018 - 2022 (USD Million)
  • TABLE 46 Acute & chronic pain market size, 2023 - 2032 (USD Million)
  • TABLE 47 Other applications market size, 2018 - 2022 (USD Million)
  • TABLE 48 Other applications market size, 2023 - 2032 (USD Million)
  • TABLE 49 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 50 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 51 Topical market size, 2018 - 2022 (USD Million)
  • TABLE 52 Topical market size, 2023 - 2032 (USD Million)
  • TABLE 53 Parenteral market size, 2018 - 2022 (USD Million)
  • TABLE 54 Parenteral market size, 2023 - 2032 (USD Million)
  • TABLE 55 Other routes of administration market size, 2018 - 2022 (USD Million)
  • TABLE 56 Other routes of administration market size, 2023 - 2032 (USD Million)
  • TABLE 57 Hospital pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 58 Hospital pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 59 Retail pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 60 Retail pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 61 Online pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 62 Online pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 63 North America branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 64 North America branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 65 North America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 66 North America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 67 North America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 68 North America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 69 North America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 North America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 North America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 72 North America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 73 U.S. branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 74 U.S. branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 75 U.S. branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 76 U.S. branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 77 U.S. branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 78 U.S. branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 79 U.S. branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 80 U.S. branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 81 Canada branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 82 Canada branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 83 Canada branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 84 Canada branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 85 Canada branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 86 Canada branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 87 Canada branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 88 Canada branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 89 Europe branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 90 Europe branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 91 Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 92 Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 93 Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 94 Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 95 Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 96 Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 97 Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 98 Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 99 Germany branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 100 Germany branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 101 Germany branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 102 Germany branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 103 Germany branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 104 Germany branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 105 Germany branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 106 Germany branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 107 UK branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 108 UK branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 109 UK branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 110 UK branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 111 UK branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 112 UK branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 113 UK branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 114 UK branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 115 France branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 116 France branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 117 France branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 118 France branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 119 France branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 France branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 France branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 122 France branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 123 Spain branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 124 Spain branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 125 Spain branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 126 Spain branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 127 Spain branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Spain branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Spain branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 130 Spain branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 131 Italy branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 132 Italy branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 133 Italy branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 134 Italy branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 135 Italy branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Italy branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Italy branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 138 Italy branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 143 Rest of Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Rest of Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Rest of Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 146 Rest of Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 149 Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 150 Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 151 Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 152 Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 153 Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 156 Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 157 Japan branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 158 Japan branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 159 Japan branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 160 Japan branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 161 Japan branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Japan branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 163 Japan branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 164 Japan branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 165 China branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 166 China branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 167 China branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 168 China branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 169 China branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 China branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 China branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 172 China branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 173 India branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 174 India branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 175 India branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 176 India branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 177 India branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 India branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 India branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 180 India branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 181 Australia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 182 Australia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 183 Australia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 184 Australia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 185 Australia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 186 Australia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 187 Australia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 188 Australia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 203 Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 204 Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 205 Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 206 Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 211 Brazil branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 212 Brazil branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 213 Brazil branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 214 Brazil branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 219 Mexico branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 220 Mexico branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 221 Mexico branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 222 Mexico branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 227 Rest of Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 228 Rest of Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 229 Rest of Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 230 Rest of Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 237 Middle East & Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 238 Middle East & Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 239 Middle East & Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 240 Middle East & Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 241 Saudi Arabia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 242 Saudi Arabia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 243 Saudi Arabia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 244 Saudi Arabia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 245 Saudi Arabia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 246 Saudi Arabia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 249 South Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 250 South Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 251 South Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 252 South Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 253 South Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 254 South Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 255 South Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 256 South Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East and Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East and Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East and Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East and Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 261 Rest of Middle East and Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 262 Rest of Middle East and Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 263 Rest of Middle East and Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 264 Rest of Middle East and Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Branded generics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022
目次
Product Code: 6565

Global Branded Generics Market size will exhibit an appreciable growth rate between 2023 and 2032. Government initiatives aimed at promoting generic products can have a stimulating effect on the market. In September 2023, the Swiss government approved changes to the Ordinance on Health Insurance, the Ordinance on Health Care Services, and the Ordinance on Medicinal Products, scheduled to be implemented on January 1, 2024. These revisions aim to make generic drugs more cost-effective compared to their brand-name counterparts while also raising patients' co-payments for selecting pricier options. This strategic move is designed to achieve annual savings of CHF 250 million, equivalent to $275 million.

By encouraging the use of more affordable generic alternatives, government policies create a competitive environment, prompting pharmaceutical companies to innovate in producing branded generic products. This competition can lead to a wider range of high-quality, cost-effective branded generics, benefiting consumers with increased choices and potentially lower prices in the pharmaceutical market.

The overall branded generics market is categorized based on drug class, application, route of administration, distribution channel, and region.

The cardiovascular disease segment could dominate the application landscape of the branded generics industry by 2032. Patients and healthcare professionals often prefer trusted brand names for critical medications, ensuring reliability and quality. Additionally, branded generics may offer specific formulations or delivery methods that cater to patient preferences and needs. This demand is further propelled by a growing awareness of cardiovascular health and a focus on effective, well-established treatments.

Topical branded generics market will demonstrate a healthy growth rate through 2032. Sales of topical branded generics are on the rise due to their effectiveness, affordability, and familiarity. Consumers trust well-known brand names for skin and healthcare products, making them a preferred choice. Topical branded generics often offer the same quality and performance as their brand-name counterparts at a lower cost, appealing to cost-conscious consumers. The increasing awareness of skin health and the availability of these trusted alternatives contribute to their growing popularity in the market.

Europe branded generics industry is experiencing robust growth due to several key factors. European consumers prioritize quality and trust established brand names for pharmaceuticals, even in generic forms. Additionally, healthcare systems in the region encourage the use of cost-effective generics, benefiting both patients and government budgets. Regulatory frameworks also support the growth of branded generics, creating a favorable environment for pharmaceutical companies to offer these trusted alternatives.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Branded generics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug class trends
    • 2.1.4 Application trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Branded Generics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence rate of chronic diseases
      • 3.2.1.2 Rising number of expired patents
      • 3.2.1.3 Increasing government initiatives to promote generic products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Competition from standard generics and brand-name drugs
      • 3.2.2.2 Regulatory barriers
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Branded Generics Market, By Drug Class, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Anti-hypertensive
  • 5.3 Hormones
  • 5.4 Antimetabolites
  • 5.5 Anti-depressants
  • 5.6 Alkylating agents
  • 5.7 Lipid lowering drugs
  • 5.8 Anti-epileptics
  • 5.9 Anti-psychotics
  • 5.10 Other drug classes

Chapter 6 Branded Generics Market, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Oncology
  • 6.3 Cardiovascular diseases
  • 6.4 Neurological diseases
  • 6.5 Gastrointestinal diseases
  • 6.6 Dermatological diseases
  • 6.7 Acute & chronic pain
  • 6.8 Other applications

Chapter 7 Branded Generics Market, By Route of Administration, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Topical
  • 7.4 Parenteral
  • 7.5 Other routes of administration

Chapter 8 Branded Generics Market, By Distribution Channel, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Branded Generics Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Teva Pharmaceutical Industries Ltd.
  • 10.2 Lupin
  • 10.3 Sanofi
  • 10.4 Sun Pharmaceutical Industries, Ltd.
  • 10.5 Dr. Reddy's Laboratories Ltd
  • 10.6 Endo International plc
  • 10.7 Pfizer, Inc.
  • 10.8 Viatris, Inc.
  • 10.9 Abbott Laboratories
  • 10.10 Sandoz